cik stringlengths 10 10 | companyName stringlengths 5 60 | ticker stringlengths 1 7 ⌀ | exchange stringclasses 3
values | sic stringdate 0100-01-01 00:00:00 8744-01-01 00:00:00 ⌀ | sicDescription stringclasses 174
values | stateOfIncorporation stringclasses 52
values | fiscalYearEnd stringdate 0101-01-01 00:00:00 1231-01-01 00:00:00 ⌀ | entityType stringclasses 3
values | accessionNumber stringlengths 20 20 | formType stringclasses 22
values | filingDate timestamp[s]date 2023-01-31 00:00:00 2026-07-31 00:00:00 | reportDate timestamp[s]date 2022-12-31 00:00:00 2026-07-30 00:00:00 ⌀ | acceptanceDateTime stringlengths 24 24 ⌀ | items stringclasses 60
values | fileNumber stringlengths 9 13 ⌀ | sizeBytes int64 3.99k 177M ⌀ | isXBRL bool 2
classes | primaryDocument stringlengths 9 36 | primaryDocDescription stringclasses 89
values | filingIndexUrl stringlengths 94 97 | documentUrl stringlengths 75 103 | matchedFullTextQuery stringclasses 12
values | retrievedAt timestamp[s]date 2026-08-02 21:56:15 2026-08-02 23:14:36 | _run_id stringclasses 63
values | _dataset_id stringclasses 63
values | financials unknown |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0001860782 | 2seventy bio, Inc. | null | null | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001860782-25-000024 | 10-K | 2025-03-25T00:00:00 | 2024-12-31T00:00:00 | 2025-03-25T16:16:05.000Z | null | 001-40791 | 12,100,667 | true | tsvt-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1860782/000186078225000024/0001860782-25-000024-index.htm | https://www.sec.gov/Archives/edgar/data/1860782/000186078225000024/tsvt-20241231.htm | null | 2026-08-02T22:31:48 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 37862000,
"revenueFiscalYear": 2024,
"revenueForm": "10-K",
"netIncome": -57247000,
"netIncomeFiscalYear": 2024,
"netIncomeForm": "10-K",
"totalAssets": 479510000,
"totalAssetsFiscalYear": 2024,
"totalAssetsForm": "10-K",
"totalLiabilities": 268704000,
"totalLiabilitiesFiscalYear": 20... |
0001946563 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001554855-26-000467 | 10-K | 2026-03-30T00:00:00 | 2025-12-31T00:00:00 | 2026-03-30T17:29:46.000Z | null | 001-41719 | 15,186,247 | true | sxtp-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/0001554855-26-000467-index.htm | https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm | null | 2026-08-02T22:31:50 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 1005471,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -7365158,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 5366211,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1986795,
"totalLiabilitiesFiscalYear": 2025,
... |
0001946563 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001013762-25-003343 | 10-K | 2025-03-27T00:00:00 | 2024-12-31T00:00:00 | 2025-03-27T16:01:45.000Z | null | 001-41719 | 11,297,703 | true | ea0232429-10k_60degrees.htm | ANNUAL REPORT | https://www.sec.gov/Archives/edgar/data/1946563/000101376225003343/0001013762-25-003343-index.htm | https://www.sec.gov/Archives/edgar/data/1946563/000101376225003343/ea0232429-10k_60degrees.htm | null | 2026-08-02T22:31:50 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 1005471,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -7365158,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 5366211,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 1986795,
"totalLiabilitiesFiscalYear": 2025,
... |
0001785173 | 89bio, Inc. | null | null | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0000950170-25-029243 | 10-K | 2025-02-27T00:00:00 | 2024-12-31T00:00:00 | 2025-02-27T17:20:30.000Z | null | 001-39122 | 17,726,198 | true | etnb-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/0000950170-25-029243-index.htm | https://www.sec.gov/Archives/edgar/data/1785173/000095017025029243/etnb-20241231.htm | null | 2026-08-02T22:31:52 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -367079000,
"netIncomeFiscalYear": 2024,
"netIncomeForm": "10-K",
"totalAssets": 478685000,
"totalAssetsFiscalYear": 2024,
"totalAssetsForm": "10-K",
"totalLiabilities": 77896000,
"totalLiabilitiesFiscalYear": 2024,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 400789000,
"s... |
0001774857 | Aardvark Therapeutics, Inc. | AARD | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001193125-26-119770 | 10-K | 2026-03-23T00:00:00 | 2025-12-31T00:00:00 | 2026-03-23T20:19:11.000Z | null | 001-42513 | 36,833,384 | true | ck0001774857-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1774857/000119312526119770/0001193125-26-119770-index.htm | https://www.sec.gov/Archives/edgar/data/1774857/000119312526119770/ck0001774857-20251231.htm | null | 2026-08-02T22:31:54 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -57591000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 117181000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 10548000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 106633000,
"st... |
0001774857 | Aardvark Therapeutics, Inc. | AARD | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0000950170-25-047835 | 10-K | 2025-03-31T00:00:00 | 2024-12-31T00:00:00 | 2025-03-31T20:45:05.000Z | null | 001-42513 | 26,832,605 | false | aard_10k_20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1774857/000095017025047835/0000950170-25-047835-index.htm | https://www.sec.gov/Archives/edgar/data/1774857/000095017025047835/aard_10k_20241231.htm | null | 2026-08-02T22:31:54 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -57591000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 117181000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 10548000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 106633000,
"st... |
0000001800 | ABBOTT LABORATORIES | ABT | NYSE | 2834 | Pharmaceutical Preparations | IL | 1231 | operating | 0001628280-26-010185 | 10-K | 2026-02-20T00:00:00 | 2025-12-31T00:00:00 | 2026-02-20T21:05:29.000Z | null | 001-02189 | 15,427,521 | true | abt-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm | null | 2026-08-02T22:31:55 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | null |
0000001800 | ABBOTT LABORATORIES | ABT | NYSE | 2834 | Pharmaceutical Preparations | IL | 1231 | operating | 0001628280-25-007110 | 10-K | 2025-02-21T00:00:00 | 2024-12-31T00:00:00 | 2025-02-21T21:07:20.000Z | null | 001-02189 | 15,611,425 | true | abt-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/abt-20241231.htm | null | 2026-08-02T22:31:55 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | null |
0001551152 | AbbVie Inc. | ABBV | NYSE | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001551152-26-000008 | 10-K | 2026-02-20T00:00:00 | 2025-12-31T00:00:00 | 2026-02-20T19:38:42.000Z | null | 001-35565 | 25,373,383 | true | abbv-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm | https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/abbv-20251231.htm | null | 2026-08-02T22:31:57 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 61160000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 1816000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 133960000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": -3270000000,
"stockholdersEquityFi... |
0001551152 | AbbVie Inc. | ABBV | NYSE | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001551152-25-000020 | 10-K | 2025-02-14T00:00:00 | 2024-12-31T00:00:00 | 2025-02-14T18:17:23.000Z | null | 001-35565 | 24,935,027 | true | abbv-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm | https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/abbv-20241231.htm | null | 2026-08-02T22:31:57 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 61160000000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 1816000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 133960000000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"stockholdersEquity": -3270000000,
"stockholdersEquityFi... |
0001703057 | AbCellera Biologics Inc. | ABCL | Nasdaq | 2834 | Pharmaceutical Preparations | A1 | 1231 | operating | 0001703057-26-000012 | 10-K | 2026-02-24T00:00:00 | 2025-12-31T00:00:00 | 2026-02-24T16:38:24.000Z | null | 001-39781 | 19,363,816 | true | abcl-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/0001703057-26-000012-index.htm | https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm | null | 2026-08-02T22:31:58 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 75128000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -146412000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1356950000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 390046000,
"totalLiabilitiesFiscalYear": ... |
0001703057 | AbCellera Biologics Inc. | ABCL | Nasdaq | 2834 | Pharmaceutical Preparations | A1 | 1231 | operating | 0001628280-25-008689 | 10-K | 2025-02-27T00:00:00 | 2024-12-31T00:00:00 | 2025-02-27T16:24:20.000Z | null | 001-39781 | 17,364,089 | true | abcl-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1703057/000162828025008689/0001628280-25-008689-index.htm | https://www.sec.gov/Archives/edgar/data/1703057/000162828025008689/abcl-20241231.htm | null | 2026-08-02T22:31:58 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 75128000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -146412000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1356950000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 390046000,
"totalLiabilitiesFiscalYear": ... |
0000318306 | ABEONA THERAPEUTICS INC. | ABEO | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001493152-26-010413 | 10-K | 2026-03-17T00:00:00 | 2025-12-31T00:00:00 | 2026-03-17T11:36:00.000Z | null | 001-15771 | 12,917,613 | true | form10-k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/318306/000149315226010413/0001493152-26-010413-index.htm | https://www.sec.gov/Archives/edgar/data/318306/000149315226010413/form10-k.htm | null | 2026-08-02T22:32:00 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 5820000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 71183000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 219570000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 60354000,
"totalLiabilitiesFiscalYear": 2025,... |
0000318306 | ABEONA THERAPEUTICS INC. | ABEO | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001493152-25-010978 | 10-K | 2025-03-20T00:00:00 | 2024-12-31T00:00:00 | 2025-03-20T11:30:47.000Z | null | 001-15771 | 9,228,482 | true | form10-k.htm | null | https://www.sec.gov/Archives/edgar/data/318306/000149315225010978/0001493152-25-010978-index.htm | https://www.sec.gov/Archives/edgar/data/318306/000149315225010978/form10-k.htm | null | 2026-08-02T22:32:00 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 5820000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 71183000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 219570000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 60354000,
"totalLiabilitiesFiscalYear": 2025,... |
0001173313 | ABVC BIOPHARMA, INC. | ABVC | Nasdaq | 2834 | Pharmaceutical Preparations | NV | 1231 | operating | 0001213900-26-023063 | 10-K | 2026-03-03T00:00:00 | 2025-12-31T00:00:00 | 2026-03-03T21:20:35.000Z | null | 001-40700 | 10,992,333 | true | ea0278313-10k_abvcbio.htm | ANNUAL REPORT | https://www.sec.gov/Archives/edgar/data/1173313/000121390026023063/0001213900-26-023063-index.htm | https://www.sec.gov/Archives/edgar/data/1173313/000121390026023063/ea0278313-10k_abvcbio.htm | null | 2026-08-02T22:32:02 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 509589,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -7908554,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 21062203,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 7764723,
"totalLiabilitiesFiscalYear": 2025,
... |
0001173313 | ABVC BIOPHARMA, INC. | ABVC | Nasdaq | 2834 | Pharmaceutical Preparations | NV | 1231 | operating | 0001213900-25-032118 | 10-K | 2025-04-15T00:00:00 | 2024-12-31T00:00:00 | 2025-04-15T20:23:46.000Z | null | 001-40700 | 15,780,158 | true | ea0232540-10k_abvcbio.htm | ANNUAL REPORT | https://www.sec.gov/Archives/edgar/data/1173313/000121390025032118/0001213900-25-032118-index.htm | https://www.sec.gov/Archives/edgar/data/1173313/000121390025032118/ea0232540-10k_abvcbio.htm | null | 2026-08-02T22:32:02 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 509589,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -7908554,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 21062203,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 7764723,
"totalLiabilitiesFiscalYear": 2025,
... |
0001070494 | ACADIA PHARMACEUTICALS INC | ACAD | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001193125-26-072519 | 10-K | 2026-02-26T00:00:00 | 2025-12-31T00:00:00 | 2026-02-26T00:22:59.000Z | null | 000-50768 | 19,407,292 | true | acad-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1070494/000119312526072519/0001193125-26-072519-index.htm | https://www.sec.gov/Archives/edgar/data/1070494/000119312526072519/acad-20251231.htm | null | 2026-08-02T22:32:03 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 1071505000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 391000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1564195000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 336805000,
"totalLiabilitiesFiscalYear":... |
0001070494 | ACADIA PHARMACEUTICALS INC | ACAD | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0000950170-25-029253 | 10-K | 2025-02-27T00:00:00 | 2024-12-31T00:00:00 | 2025-02-27T22:26:09.000Z | null | 000-50768 | 19,850,382 | true | acad-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1070494/000095017025029253/0000950170-25-029253-index.htm | https://www.sec.gov/Archives/edgar/data/1070494/000095017025029253/acad-20241231.htm | null | 2026-08-02T22:32:03 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 1071505000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": 391000000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1564195000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 336805000,
"totalLiabilitiesFiscalYear":... |
0001850767 | Accustem Sciences Inc. | ACUT | OTC | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001493152-26-016559 | 10-K | 2026-04-14T00:00:00 | 2025-12-31T00:00:00 | 2026-04-14T20:30:41.000Z | null | 000-56257 | 5,413,892 | true | form10-k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1850767/000149315226016559/0001493152-26-016559-index.htm | https://www.sec.gov/Archives/edgar/data/1850767/000149315226016559/form10-k.htm | null | 2026-08-02T22:32:06 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -1756096,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1549446,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 4951071,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": -3401625,
"stockho... |
0001850767 | Accustem Sciences Inc. | ACUT | OTC | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001641172-25-002594 | 10-K | 2025-04-03T00:00:00 | 2024-12-31T00:00:00 | 2025-04-03T21:00:36.000Z | null | 000-56257 | 5,465,926 | true | form10-k.htm | null | https://www.sec.gov/Archives/edgar/data/1850767/000164117225002594/0001641172-25-002594-index.htm | https://www.sec.gov/Archives/edgar/data/1850767/000164117225002594/form10-k.htm | null | 2026-08-02T22:32:06 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -1756096,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 1549446,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 4951071,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": -3401625,
"stockho... |
0001962918 | ACELYRIN, Inc. | null | null | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001962918-25-000022 | 10-K | 2025-03-19T00:00:00 | 2024-12-31T00:00:00 | 2025-03-19T16:04:33.000Z | null | 001-41696 | 16,684,388 | true | slrn-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1962918/000196291825000022/0001962918-25-000022-index.htm | https://www.sec.gov/Archives/edgar/data/1962918/000196291825000022/slrn-20241231.htm | null | 2026-08-02T22:32:08 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -248226000,
"netIncomeFiscalYear": 2024,
"netIncomeForm": "10-K",
"totalAssets": 491141000,
"totalAssetsFiscalYear": 2024,
"totalAssetsForm": "10-K",
"totalLiabilities": 32848000,
"totalLiabilitiesFiscalYear": 2024,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 458293000,
"s... |
0001557746 | Aclaris Therapeutics, Inc. | ACRS | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001104659-26-020540 | 10-K | 2026-02-26T00:00:00 | 2025-12-31T00:00:00 | 2026-02-26T21:31:23.000Z | null | 001-37581 | 9,992,713 | true | acrs-20251231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/0001104659-26-020540-index.htm | https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm | null | 2026-08-02T22:32:10 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 7826000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -64923000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 160460000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 57378000,
"totalLiabilitiesFiscalYear": 2025... |
0001557746 | Aclaris Therapeutics, Inc. | ACRS | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001558370-25-001819 | 10-K | 2025-02-27T00:00:00 | 2024-12-31T00:00:00 | 2025-02-27T21:30:47.000Z | null | 001-37581 | 13,124,783 | true | acrs-20241231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1557746/000155837025001819/0001558370-25-001819-index.htm | https://www.sec.gov/Archives/edgar/data/1557746/000155837025001819/acrs-20241231x10k.htm | null | 2026-08-02T22:32:10 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 7826000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -64923000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 160460000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 57378000,
"totalLiabilitiesFiscalYear": 2025... |
0001781174 | Acrivon Therapeutics, Inc. | ACRV | Nasdaq | 2834 | Pharmaceutical Preparations | null | 1231 | operating | 0001193125-26-115123 | 10-K | 2026-03-19T00:00:00 | 2025-12-31T00:00:00 | 2026-03-19T11:10:31.000Z | null | 001-41551 | 12,398,081 | true | acrv-20251231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1781174/000119312526115123/0001193125-26-115123-index.htm | https://www.sec.gov/Archives/edgar/data/1781174/000119312526115123/acrv-20251231.htm | null | 2026-08-02T22:32:11 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -77905000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 129717000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 17201000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 112516000,
"st... |
0001781174 | Acrivon Therapeutics, Inc. | ACRV | Nasdaq | 2834 | Pharmaceutical Preparations | null | 1231 | operating | 0000950170-25-046056 | 10-K | 2025-03-27T00:00:00 | 2024-12-31T00:00:00 | 2025-03-27T20:06:36.000Z | null | 001-41551 | 100,633,020 | true | acrv-20241231.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1781174/000095017025046056/0000950170-25-046056-index.htm | https://www.sec.gov/Archives/edgar/data/1781174/000095017025046056/acrv-20241231.htm | null | 2026-08-02T22:32:11 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -77905000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 129717000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 17201000,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 112516000,
"st... |
0001388320 | Actinium Pharmaceuticals, Inc. | ATNM | NYSE | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001213900-26-036504 | 10-K | 2026-03-30T00:00:00 | 2025-12-31T00:00:00 | 2026-03-30T21:39:32.000Z | null | 001-36374 | 9,290,028 | true | ea0279291-10k_actinium.htm | ANNUAL REPORT | https://www.sec.gov/Archives/edgar/data/1388320/000121390026036504/0001213900-26-036504-index.htm | https://www.sec.gov/Archives/edgar/data/1388320/000121390026036504/ea0279291-10k_actinium.htm | null | 2026-08-02T22:32:14 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 90000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -33887000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 51775000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 43941000,
"totalLiabilitiesFiscalYear": 2025,
... |
0001388320 | Actinium Pharmaceuticals, Inc. | ATNM | NYSE | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001213900-25-026371 | 10-K | 2025-03-31T00:00:00 | 2024-12-31T00:00:00 | 2025-03-31T21:00:42.000Z | null | 001-36374 | 6,759,713 | true | ea0232395-10k_actinium.htm | ANNUAL REPORT | https://www.sec.gov/Archives/edgar/data/1388320/000121390025026371/0001213900-25-026371-index.htm | https://www.sec.gov/Archives/edgar/data/1388320/000121390025026371/ea0232395-10k_actinium.htm | null | 2026-08-02T22:32:14 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"revenue": 90000,
"revenueFiscalYear": 2025,
"revenueForm": "10-K",
"netIncome": -33887000,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 51775000,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 43941000,
"totalLiabilitiesFiscalYear": 2025,
... |
0001652935 | ACTUATE THERAPEUTICS, INC. | ACTU | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001683168-26-002257 | 10-K | 2026-03-26T00:00:00 | 2025-12-31T00:00:00 | 2026-03-26T20:00:51.000Z | null | 001-42139 | 9,394,211 | true | actuate_i10k-123125.htm | FORM 10-K FOR DEC 2025 | https://www.sec.gov/Archives/edgar/data/1652935/000168316826002257/0001683168-26-002257-index.htm | https://www.sec.gov/Archives/edgar/data/1652935/000168316826002257/actuate_i10k-123125.htm | null | 2026-08-02T22:32:15 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -22227852,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 14035910,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6111907,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 7924003,
"stockh... |
0001652935 | ACTUATE THERAPEUTICS, INC. | ACTU | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001683168-25-001581 | 10-K | 2025-03-13T00:00:00 | 2024-12-31T00:00:00 | 2025-03-13T20:30:23.000Z | null | 001-42139 | 9,042,037 | true | actuate_i10k-123124.htm | FORM 10-K FOR 2024 | https://www.sec.gov/Archives/edgar/data/1652935/000168316825001581/0001683168-25-001581-index.htm | https://www.sec.gov/Archives/edgar/data/1652935/000168316825001581/actuate_i10k-123124.htm | null | 2026-08-02T22:32:15 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -22227852,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 14035910,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 6111907,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 7924003,
"stockh... |
0001736243 | Acurx Pharmaceuticals, Inc. | ACXP | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001104659-26-027052 | 10-K | 2026-03-12T00:00:00 | 2025-12-31T00:00:00 | 2026-03-12T20:06:12.000Z | null | 001-40536 | 8,499,154 | true | acxp-20251231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/0001104659-26-027052-index.htm | https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k.htm | null | 2026-08-02T22:32:17 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -7966538,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 7689535,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 2420943,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 5268592,
"stockhol... |
0001736243 | Acurx Pharmaceuticals, Inc. | ACXP | Nasdaq | 2834 | Pharmaceutical Preparations | DE | 1231 | operating | 0001558370-25-003117 | 10-K | 2025-03-17T00:00:00 | 2024-12-31T00:00:00 | 2025-03-17T20:05:27.000Z | null | 001-40536 | 7,660,204 | true | acxp-20241231x10k.htm | 10-K | https://www.sec.gov/Archives/edgar/data/1736243/000155837025003117/0001558370-25-003117-index.htm | https://www.sec.gov/Archives/edgar/data/1736243/000155837025003117/acxp-20241231x10k.htm | null | 2026-08-02T22:32:17 | w6CbSNj7r0V0SkODz | yy0yTgEnnKPvcWVrY | {
"netIncome": -7966538,
"netIncomeFiscalYear": 2025,
"netIncomeForm": "10-K",
"totalAssets": 7689535,
"totalAssetsFiscalYear": 2025,
"totalAssetsForm": "10-K",
"totalLiabilities": 2420943,
"totalLiabilitiesFiscalYear": 2025,
"totalLiabilitiesForm": "10-K",
"stockholdersEquity": 5268592,
"stockhol... |
0000320193 | Apple Inc. | AAPL | Nasdaq | 3571 | Electronic Computers | CA | 0926 | operating | 0001308179-26-000008 | DEF 14A | 2026-01-08T00:00:00 | 2026-02-24T00:00:00 | 2026-01-08T21:31:36.000Z | null | 001-36743 | 13,682,253 | true | aapl014016-def14a.htm | DEFINITIVE PROXY STATEMENT | https://www.sec.gov/Archives/edgar/data/320193/000130817926000008/0001308179-26-000008-index.htm | https://www.sec.gov/Archives/edgar/data/320193/000130817926000008/aapl014016-def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000320193 | Apple Inc. | AAPL | Nasdaq | 3571 | Electronic Computers | CA | 0926 | operating | 0001308179-25-000008 | DEF 14A | 2025-01-10T00:00:00 | 2025-02-25T00:00:00 | 2025-01-10T21:31:18.000Z | null | 001-36743 | 32,132,682 | true | aapl4359751-def14a.htm | DEFINITIVE PROXY STATEMENT | https://www.sec.gov/Archives/edgar/data/320193/000130817925000008/0001308179-25-000008-index.htm | https://www.sec.gov/Archives/edgar/data/320193/000130817925000008/aapl4359751-def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000320193 | Apple Inc. | AAPL | Nasdaq | 3571 | Electronic Computers | CA | 0926 | operating | 0001308179-24-000010 | DEF 14A | 2024-01-11T00:00:00 | 2024-02-28T00:00:00 | 2024-01-11T21:30:29.000Z | null | 001-36743 | 9,051,163 | true | laapl2024_def14a.htm | APPLE INC. - DEF 14A | https://www.sec.gov/Archives/edgar/data/320193/000130817924000010/0001308179-24-000010-index.htm | https://www.sec.gov/Archives/edgar/data/320193/000130817924000010/laapl2024_def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000789019 | MICROSOFT CORP | MSFT | Nasdaq | 7372 | Services-Prepackaged Software | WA | 0630 | operating | 0001193125-25-245150 | DEF 14A | 2025-10-21T00:00:00 | 2025-12-05T00:00:00 | 2025-10-21T16:16:13.000Z | null | 001-37845 | 26,384,259 | true | d908201ddef14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/789019/000119312525245150/0001193125-25-245150-index.htm | https://www.sec.gov/Archives/edgar/data/789019/000119312525245150/d908201ddef14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000789019 | MICROSOFT CORP | MSFT | Nasdaq | 7372 | Services-Prepackaged Software | WA | 0630 | operating | 0001193125-24-242883 | DEF 14A | 2024-10-24T00:00:00 | 2024-12-10T00:00:00 | 2024-10-24T16:31:13.000Z | null | 001-37845 | 25,236,650 | true | d858775ddef14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/789019/000119312524242883/0001193125-24-242883-index.htm | https://www.sec.gov/Archives/edgar/data/789019/000119312524242883/d858775ddef14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001045810 | NVIDIA CORP | NVDA | Nasdaq | 3674 | Semiconductors & Related Devices | DE | 0131 | operating | 0001045810-26-000036 | DEF 14A | 2026-05-12T00:00:00 | 2026-06-24T00:00:00 | 2026-05-12T20:42:13.000Z | null | 000-23985 | 19,820,545 | true | nvda-20260512.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1045810/000104581026000036/0001045810-26-000036-index.htm | https://www.sec.gov/Archives/edgar/data/1045810/000104581026000036/nvda-20260512.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001045810 | NVIDIA CORP | NVDA | Nasdaq | 3674 | Semiconductors & Related Devices | DE | 0131 | operating | 0001045810-25-000095 | DEF 14A | 2025-05-13T00:00:00 | 2025-06-25T00:00:00 | 2025-05-13T20:31:03.000Z | null | 000-23985 | 8,768,287 | true | nvda-20250512.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1045810/000104581025000095/0001045810-25-000095-index.htm | https://www.sec.gov/Archives/edgar/data/1045810/000104581025000095/nvda-20250512.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001045810 | NVIDIA CORP | NVDA | Nasdaq | 3674 | Semiconductors & Related Devices | DE | 0131 | operating | 0001045810-24-000104 | DEF 14A | 2024-05-14T00:00:00 | 2024-06-26T00:00:00 | 2024-05-14T20:08:58.000Z | null | 000-23985 | 73,319,135 | true | nvda-20240514.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1045810/000104581024000104/0001045810-24-000104-index.htm | https://www.sec.gov/Archives/edgar/data/1045810/000104581024000104/nvda-20240514.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001652044 | Alphabet Inc. | GOOGL | Nasdaq | 7370 | Services-Computer Programming, Data Processing, Etc. | DE | 1231 | operating | 0001308179-26-000342 | DEF 14A | 2026-04-24T00:00:00 | 2026-06-05T00:00:00 | 2026-04-24T20:15:37.000Z | null | 001-37580 | 23,328,825 | true | goog-20260424.htm | DEFINITIVE PROXY STATEMENT | https://www.sec.gov/Archives/edgar/data/1652044/000130817926000342/0001308179-26-000342-index.htm | https://www.sec.gov/Archives/edgar/data/1652044/000130817926000342/goog-20260424.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001652044 | Alphabet Inc. | GOOGL | Nasdaq | 7370 | Services-Computer Programming, Data Processing, Etc. | DE | 1231 | operating | 0001308179-25-000511 | DEF 14A | 2025-04-25T00:00:00 | 2025-06-06T00:00:00 | 2025-04-25T20:15:43.000Z | null | 001-37580 | 12,344,613 | true | goog012701-def14a.htm | DEFINITIVE PROXY STATEMENT | https://www.sec.gov/Archives/edgar/data/1652044/000130817925000511/0001308179-25-000511-index.htm | https://www.sec.gov/Archives/edgar/data/1652044/000130817925000511/goog012701-def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001652044 | Alphabet Inc. | GOOGL | Nasdaq | 7370 | Services-Computer Programming, Data Processing, Etc. | DE | 1231 | operating | 0001308179-24-000612 | DEF 14A | 2024-04-26T00:00:00 | 2024-06-07T00:00:00 | 2024-04-26T20:35:43.000Z | null | 001-37580 | 7,113,871 | true | lgoog2024_def14a.htm | ALPHABET INC. - DEF 14A | https://www.sec.gov/Archives/edgar/data/1652044/000130817924000612/0001308179-24-000612-index.htm | https://www.sec.gov/Archives/edgar/data/1652044/000130817924000612/lgoog2024_def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001018724 | AMAZON COM INC | AMZN | Nasdaq | 5961 | Retail-Catalog & Mail-Order Houses | DE | 1231 | operating | 0001104659-26-041026 | DEF 14A | 2026-04-09T00:00:00 | 2026-05-20T00:00:00 | 2026-04-08T21:47:56.000Z | null | 001-43202 | 5,918,401 | true | tm261382-1_def14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1018724/000110465926041026/0001104659-26-041026-index.htm | https://www.sec.gov/Archives/edgar/data/1018724/000110465926041026/tm261382-1_def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001018724 | AMAZON COM INC | AMZN | Nasdaq | 5961 | Retail-Catalog & Mail-Order Houses | DE | 1231 | operating | 0001104659-25-033442 | DEF 14A | 2025-04-10T00:00:00 | 2025-05-21T00:00:00 | 2025-04-09T21:38:44.000Z | null | 000-22513 | 6,635,066 | true | tm252295-1_def14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1018724/000110465925033442/0001104659-25-033442-index.htm | https://www.sec.gov/Archives/edgar/data/1018724/000110465925033442/tm252295-1_def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001018724 | AMAZON COM INC | AMZN | Nasdaq | 5961 | Retail-Catalog & Mail-Order Houses | DE | 1231 | operating | 0001104659-24-045910 | DEF 14A | 2024-04-11T00:00:00 | 2024-05-22T00:00:00 | 2024-04-10T22:14:29.000Z | null | 000-22513 | 8,289,378 | true | tm2329302d4_def14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1018724/000110465924045910/0001104659-24-045910-index.htm | https://www.sec.gov/Archives/edgar/data/1018724/000110465924045910/tm2329302d4_def14a.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001326801 | Meta Platforms, Inc. | META | Nasdaq | 7370 | Services-Computer Programming, Data Processing, Etc. | DE | 1231 | operating | 0001628280-26-025532 | DEF 14A | 2026-04-16T00:00:00 | 2025-12-31T00:00:00 | 2026-04-16T20:34:06.000Z | null | 001-35551 | 19,211,959 | true | meta-20260416.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1326801/000162828026025532/0001628280-26-025532-index.htm | https://www.sec.gov/Archives/edgar/data/1326801/000162828026025532/meta-20260416.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001326801 | Meta Platforms, Inc. | META | Nasdaq | 7370 | Services-Computer Programming, Data Processing, Etc. | DE | 1231 | operating | 0001326801-25-000040 | DEF 14A | 2025-04-17T00:00:00 | 2024-12-31T00:00:00 | 2025-04-17T21:08:22.000Z | null | 001-35551 | 36,219,519 | true | meta-20250417.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/1326801/000132680125000040/0001326801-25-000040-index.htm | https://www.sec.gov/Archives/edgar/data/1326801/000132680125000040/meta-20250417.htm | null | 2026-08-02T22:31:38 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000019617 | JPMORGAN CHASE & CO | JPM | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000019617-26-000096 | DEF 14A | 2026-04-06T00:00:00 | 2026-04-06T00:00:00 | 2026-04-06T10:17:40.000Z | null | 001-05805 | 74,694,140 | true | jpm-20260402.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/19617/000001961726000096/0000019617-26-000096-index.htm | https://www.sec.gov/Archives/edgar/data/19617/000001961726000096/jpm-20260402.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000070858 | BANK OF AMERICA CORP /DE/ | BAC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0001193125-26-118929 | DEF 14A | 2026-03-23T00:00:00 | 2026-05-04T00:00:00 | 2026-03-23T15:02:56.000Z | null | 001-06523 | 17,442,435 | true | d43888ddef14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/70858/000119312526118929/0001193125-26-118929-index.htm | https://www.sec.gov/Archives/edgar/data/70858/000119312526118929/d43888ddef14a.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-26-000200 | DEF 14A | 2026-03-18T00:00:00 | 2025-12-31T00:00:00 | 2026-03-18T20:02:02.000Z | null | 001-02979 | 35,982,562 | true | wfc-20260318.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/72971/000007297126000200/0000072971-26-000200-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297126000200/wfc-20260318.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000072971 | WELLS FARGO & COMPANY/MN | WFC | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0000072971-25-000090 | DEF 14A | 2025-03-19T00:00:00 | 2024-12-31T00:00:00 | 2025-03-19T20:14:41.000Z | null | 001-02979 | 31,858,370 | true | wfc-20250317.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/72971/000007297125000090/0000072971-25-000090-index.htm | https://www.sec.gov/Archives/edgar/data/72971/000007297125000090/wfc-20250317.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000831001 | CITIGROUP INC | C | NYSE | 6021 | National Commercial Banks | DE | 1231 | operating | 0001206774-26-000185 | DEF 14A | 2026-04-02T00:00:00 | 2026-05-20T00:00:00 | 2026-04-02T20:16:04.000Z | null | 001-09924 | 11,611,835 | true | citi4583461-def14a.htm | DEFINITIVE PROXY STATEMENT | https://www.sec.gov/Archives/edgar/data/831001/000120677426000185/0001206774-26-000185-index.htm | https://www.sec.gov/Archives/edgar/data/831001/000120677426000185/citi4583461-def14a.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000886982 | GOLDMAN SACHS GROUP INC | GS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0001193125-26-117433 | DEF 14A | 2026-03-20T00:00:00 | 2026-04-29T00:00:00 | 2026-03-20T18:59:06.000Z | null | 001-14965 | 176,501,259 | true | gs-20260319.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/886982/000119312526117433/0001193125-26-117433-index.htm | https://www.sec.gov/Archives/edgar/data/886982/000119312526117433/gs-20260319.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0000895421 | MORGAN STANLEY | MS | NYSE | 6211 | Security Brokers, Dealers & Flotation Companies | DE | 1231 | operating | 0001140361-26-012975 | DEF 14A | 2026-04-02T00:00:00 | 2026-05-14T00:00:00 | 2026-04-02T20:02:24.000Z | null | 001-11758 | 28,203,095 | true | ny20058185x1_def14a.htm | DEF 14A | https://www.sec.gov/Archives/edgar/data/895421/000114036126012975/0001140361-26-012975-index.htm | https://www.sec.gov/Archives/edgar/data/895421/000114036126012975/ny20058185x1_def14a.htm | null | 2026-08-02T22:31:39 | vPietILTbcFBwdVX3 | NcCVvjF7d5bMCsMNf | null |
0001109448 | ALLIANCEBERNSTEIN L.P. | null | null | 6282 | Investment Advice | DE | 1231 | operating | 0001109448-26-000101 | 13F-HR | 2026-05-15T00:00:00 | 2026-03-31T00:00:00 | 2026-05-15T19:14:09.000Z | null | 028-10562 | 1,626,849 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/1109448/000110944826000101/0001109448-26-000101-index.htm | https://www.sec.gov/Archives/edgar/data/1109448/000110944826000101/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:40 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0001109448 | ALLIANCEBERNSTEIN L.P. | null | null | 6282 | Investment Advice | DE | 1231 | operating | 0001109448-26-000021 | 13F-HR | 2026-02-17T00:00:00 | 2025-12-31T00:00:00 | 2026-02-17T20:15:51.000Z | null | 028-10562 | 1,629,051 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/1109448/000110944826000021/0001109448-26-000021-index.htm | https://www.sec.gov/Archives/edgar/data/1109448/000110944826000021/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:40 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0001838615 | AlTi Global, Inc. | ALTI | Nasdaq | 6282 | Investment Advice | DE | 1231 | operating | 0001838615-26-000003 | 13F-HR | 2026-05-07T00:00:00 | 2026-03-31T00:00:00 | 2026-05-07T20:38:31.000Z | null | 028-23888 | 456,637 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/1838615/000183861526000003/0001838615-26-000003-index.htm | https://www.sec.gov/Archives/edgar/data/1838615/000183861526000003/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:40 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0001838615 | AlTi Global, Inc. | ALTI | Nasdaq | 6282 | Investment Advice | DE | 1231 | operating | 0001838615-26-000002 | 13F-HR | 2026-02-13T00:00:00 | 2025-12-31T00:00:00 | 2026-02-13T21:44:03.000Z | null | 028-23888 | 463,226 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/1838615/000183861526000002/0001838615-26-000002-index.htm | https://www.sec.gov/Archives/edgar/data/1838615/000183861526000002/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:40 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0000820027 | AMERIPRISE FINANCIAL INC | AMP | NYSE | 6282 | Investment Advice | DE | 1231 | operating | 0001193125-26-307058 | 13F-HR/A | 2026-07-17T00:00:00 | 2026-03-31T00:00:00 | 2026-07-17T14:26:11.000Z | null | 028-00139 | 5,716 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/820027/000119312526307058/0001193125-26-307058-index.htm | https://www.sec.gov/Archives/edgar/data/820027/000119312526307058/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:40 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0000820027 | AMERIPRISE FINANCIAL INC | AMP | NYSE | 6282 | Investment Advice | DE | 1231 | operating | 0001193125-26-307051 | 13F-HR/A | 2026-07-17T00:00:00 | 2026-03-31T00:00:00 | 2026-07-17T14:22:19.000Z | null | 028-00139 | 5,567,905 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/820027/000119312526307051/0001193125-26-307051-index.htm | https://www.sec.gov/Archives/edgar/data/820027/000119312526307051/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:40 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0001393818 | Blackstone Inc. | BX | NYSE | 6282 | Investment Advice | DE | 1231 | operating | 0001193125-26-226672 | 13F-HR | 2026-05-15T00:00:00 | 2026-03-31T00:00:00 | 2026-05-15T20:06:05.000Z | null | 028-13114 | 224,653 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/1393818/000119312526226672/0001193125-26-226672-index.htm | https://www.sec.gov/Archives/edgar/data/1393818/000119312526226672/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:44 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0001393818 | Blackstone Inc. | BX | NYSE | 6282 | Investment Advice | DE | 1231 | operating | 0001193125-26-226614 | 13F-HR/A | 2026-05-15T00:00:00 | 2025-12-31T00:00:00 | 2026-05-15T20:04:03.000Z | null | 028-13114 | 7,436 | false | xslForm13F_X02/primary_doc.xml | null | https://www.sec.gov/Archives/edgar/data/1393818/000119312526226614/0001193125-26-226614-index.htm | https://www.sec.gov/Archives/edgar/data/1393818/000119312526226614/xslForm13F_X02/primary_doc.xml | null | 2026-08-02T22:31:44 | WffmrfeqfQrl1Jgcu | CPqgIo7F7l8hALMOV | null |
0001877461 | 1606 CORP. | CBDW | OTC | 7372 | Services-Prepackaged Software | NV | 1231 | operating | 0001477932-26-000252 | S-1 | 2026-01-16T00:00:00 | null | 2026-01-16T21:06:19.000Z | null | 333-292787 | 5,186,491 | true | cbdw_s1.htm | FORM S-1 | https://www.sec.gov/Archives/edgar/data/1877461/000147793226000252/0001477932-26-000252-index.htm | https://www.sec.gov/Archives/edgar/data/1877461/000147793226000252/cbdw_s1.htm | null | 2026-08-02T22:31:38 | KwnLhHa2McjlwKCrn | uJIKEZ9AHVBcMCLiR | null |
0002084227 | Advasa Holdings, Inc. | ADBT | null | 7372 | Services-Prepackaged Software | DE | 0331 | other | 0001493152-26-032985 | S-1/A | 2026-07-13T00:00:00 | null | 2026-07-13T18:15:06.000Z | null | 333-292013 | 1,535,831 | false | forms-1a.htm | S-1/A | https://www.sec.gov/Archives/edgar/data/2084227/000149315226032985/0001493152-26-032985-index.htm | https://www.sec.gov/Archives/edgar/data/2084227/000149315226032985/forms-1a.htm | null | 2026-08-02T22:31:44 | KwnLhHa2McjlwKCrn | uJIKEZ9AHVBcMCLiR | null |
0002084227 | Advasa Holdings, Inc. | ADBT | null | 7372 | Services-Prepackaged Software | DE | 0331 | other | 0001493152-26-030005 | S-1/A | 2026-06-25T00:00:00 | null | 2026-06-25T01:24:10.000Z | null | 333-292013 | 1,930,030 | false | forms-1a.htm | S-1/A | https://www.sec.gov/Archives/edgar/data/2084227/000149315226030005/0001493152-26-030005-index.htm | https://www.sec.gov/Archives/edgar/data/2084227/000149315226030005/forms-1a.htm | null | 2026-08-02T22:31:44 | KwnLhHa2McjlwKCrn | uJIKEZ9AHVBcMCLiR | null |
0002083452 | Shreya Acquisition Group | SAGU | NYSE | 6770 | Blank Checks | E9 | 0630 | operating | 0001829126-26-004652 | 424B4 | 2026-05-07T00:00:00 | null | 2026-05-06T22:38:05.000Z | null | 333-290228 | 2,096,381 | false | shreyaacq_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2083452/000182912626004652/0001829126-26-004652-index.htm | https://www.sec.gov/Archives/edgar/data/2083452/000182912626004652/shreyaacq_424b4.htm | initial public offering | 2026-08-02T22:31:39 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002116105 | Futurewave Acquisition Corp | FWAC | null | 6770 | Blank Checks | E9 | 0228 | other | 0001829126-26-006890 | 424B4 | 2026-06-26T00:00:00 | null | 2026-06-26T10:00:27.000Z | null | 333-295572 | 1,803,431 | false | futurewaveacq_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2116105/000182912626006890/0001829126-26-006890-index.htm | https://www.sec.gov/Archives/edgar/data/2116105/000182912626006890/futurewaveacq_424b4.htm | initial public offering | 2026-08-02T22:31:39 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002035016 | Ribbon Acquisition Corp. | RIBB | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-003970 | 424B4 | 2025-01-16T00:00:00 | null | 2025-01-16T11:15:16.000Z | null | 333-281806 | 1,962,418 | false | ea0227746-424b4_ribbon.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2035016/000121390025003970/0001213900-25-003970-index.htm | https://www.sec.gov/Archives/edgar/data/2035016/000121390025003970/ea0227746-424b4_ribbon.htm | initial public offering | 2026-08-02T22:31:39 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002106436 | Mercator Acquisition Corp. | MRCO | null | 6770 | Blank Checks | E9 | 1231 | other | 0001213900-26-076921 | 424B4 | 2026-07-10T00:00:00 | null | 2026-07-10T11:52:13.000Z | null | 333-293902 | 4,218,553 | false | ea0277572-06.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2106436/000121390026076921/0001213900-26-076921-index.htm | https://www.sec.gov/Archives/edgar/data/2106436/000121390026076921/ea0277572-06.htm | initial public offering | 2026-08-02T22:31:39 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002089536 | Cantor Equity Partners VI, Inc. | CEPS | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-26-012881 | 424B4 | 2026-02-05T00:00:00 | null | 2026-02-05T22:25:44.000Z | null | 333-292621 | 4,824,461 | false | ea0259658-05.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2089536/000121390026012881/0001213900-26-012881-index.htm | https://www.sec.gov/Archives/edgar/data/2089536/000121390026012881/ea0259658-05.htm | initial public offering | 2026-08-02T22:31:39 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002081909 | SilverBox Corp V | SBXE | NYSE | 6770 | Blank Checks | E9 | 1231 | operating | 0001104659-25-118125 | 424B4 | 2025-12-03T00:00:00 | null | 2025-12-03T21:08:34.000Z | null | 333-289783 | 2,701,928 | false | tm2522760-12_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2081909/000110465925118125/0001104659-25-118125-index.htm | https://www.sec.gov/Archives/edgar/data/2081909/000110465925118125/tm2522760-12_424b4.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002086545 | Art Technology Acquisition Corp. | ARTC | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-26-001875 | 424B4 | 2026-01-07T00:00:00 | null | 2026-01-06T22:40:00.000Z | null | 333-291966 | 4,105,318 | false | ea0259414-05.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2086545/000121390026001875/0001213900-26-001875-index.htm | https://www.sec.gov/Archives/edgar/data/2086545/000121390026001875/ea0259414-05.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002080019 | GigCapital8 Corp. | GIW | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001193125-25-230859 | 424B4 | 2025-10-06T00:00:00 | null | 2025-10-06T10:21:05.000Z | null | 333-289479 | 1,977,273 | false | d929696d424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2080019/000119312525230859/0001193125-25-230859-index.htm | https://www.sec.gov/Archives/edgar/data/2080019/000119312525230859/d929696d424b4.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002030482 | Plum Acquisition Corp, IV | PLMK | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-003871 | 424B4 | 2025-01-15T00:00:00 | null | 2025-01-15T21:42:50.000Z | null | 333-281144 | 4,781,901 | false | ea0210204-10.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2030482/000121390025003871/0001213900-25-003871-index.htm | https://www.sec.gov/Archives/edgar/data/2030482/000121390025003871/ea0210204-10.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002083989 | Aldabra 4 Liquidity Opportunity Vehicle, Inc. | ALOV | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001104659-26-005826 | 424B4 | 2026-01-22T00:00:00 | null | 2026-01-22T21:37:46.000Z | null | 333-292418 | 2,519,022 | false | tm2525322-8_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2083989/000110465926005826/0001104659-26-005826-index.htm | https://www.sec.gov/Archives/edgar/data/2083989/000110465926005826/tm2525322-8_424b4.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002050501 | Blue Water Acquisition Corp. III | BLUW | Nasdaq | 6770 | Blank Checks | null | 1231 | operating | 0001641172-25-014598 | 424B4 | 2025-06-11T00:00:00 | null | 2025-06-10T23:55:15.000Z | null | 333-285075 | 2,676,658 | false | form424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2050501/000164117225014598/0001641172-25-014598-index.htm | https://www.sec.gov/Archives/edgar/data/2050501/000164117225014598/form424b4.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002037431 | Pelican Acquisition Corp | null | null | 6770 | Blank Checks | E9 | 0131 | operating | 0001829126-25-003907 | 424B4 | 2025-05-23T00:00:00 | null | 2025-05-23T16:00:40.000Z | null | 333-286452 | 1,489,235 | false | pelicanacq_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2037431/000182912625003907/0001829126-25-003907-index.htm | https://www.sec.gov/Archives/edgar/data/2037431/000182912625003907/pelicanacq_424b4.htm | initial public offering | 2026-08-02T22:31:40 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002064683 | Cohen Circle Acquisition Corp. II | CCII | Nasdaq | 6770 | Blank Checks | null | 1231 | operating | 0001213900-25-060463 | 424B4 | 2025-07-01T00:00:00 | null | 2025-07-01T21:12:24.000Z | null | 333-287538 | 4,150,708 | false | ea0237632-09.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2064683/000121390025060463/0001213900-25-060463-index.htm | https://www.sec.gov/Archives/edgar/data/2064683/000121390025060463/ea0237632-09.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002097288 | BHAV Acquisition Corp | BHAV | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-26-032071 | 424B4 | 2026-03-20T00:00:00 | null | 2026-03-20T12:00:35.000Z | null | 333-293399 | 3,591,175 | false | ea0269733-06.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2097288/000121390026032071/0001213900-26-032071-index.htm | https://www.sec.gov/Archives/edgar/data/2097288/000121390026032071/ea0269733-06.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002053799 | Kochav Defense Acquisition Corp. | KCHV | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-048305 | 424B4 | 2025-05-28T00:00:00 | null | 2025-05-28T20:31:27.000Z | null | 333-286759 | 3,817,884 | false | ea0232069-11.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2053799/000121390025048305/0001213900-25-048305-index.htm | https://www.sec.gov/Archives/edgar/data/2053799/000121390025048305/ea0232069-11.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002122392 | Pelican Acquisition II Corp | PLCI | null | 6770 | Blank Checks | E9 | 0228 | other | 0001829126-26-007833 | 424B4 | 2026-07-24T00:00:00 | null | 2026-07-24T19:44:35.000Z | null | 333-296688 | 1,682,394 | false | pelicanacq2_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2122392/000182912626007833/0001829126-26-007833-index.htm | https://www.sec.gov/Archives/edgar/data/2122392/000182912626007833/pelicanacq2_424b4.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002069856 | HCM III ACQUISITION CORP. | HCMA | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-070835 | 424B4 | 2025-08-04T00:00:00 | null | 2025-08-02T01:47:44.000Z | null | 333-287841 | 3,960,707 | false | ea0241608-09.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2069856/000121390025070835/0001213900-25-070835-index.htm | https://www.sec.gov/Archives/edgar/data/2069856/000121390025070835/ea0241608-09.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0001846416 | Hennessy Capital Investment Corp. VII | HVII | Nasdaq | 4911 | Electric Services | DE | 1231 | operating | 0001493152-25-002806 | 424B4 | 2025-01-17T00:00:00 | null | 2025-01-17T21:31:52.000Z | null | 333-283087 | 2,968,726 | false | form424b4.htm | null | https://www.sec.gov/Archives/edgar/data/1846416/000149315225002806/0001493152-25-002806-index.htm | https://www.sec.gov/Archives/edgar/data/1846416/000149315225002806/form424b4.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002035173 | Renatus Tactical Acquisition Corp I | RTAC | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001140361-25-019435 | 424B4 | 2025-05-16T00:00:00 | null | 2025-05-16T16:59:39.000Z | null | 333-285842 | 2,404,539 | false | ny20045296x16_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2035173/000114036125019435/0001140361-25-019435-index.htm | https://www.sec.gov/Archives/edgar/data/2035173/000114036125019435/ny20045296x16_424b4.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002056263 | Columbus Circle Capital Corp. I | null | null | 6770 | Blank Checks | DE | 1231 | operating | 0001213900-25-044982 | 424B4 | 2025-05-19T00:00:00 | null | 2025-05-16T18:31:02.000Z | null | 333-286778 | 4,565,897 | false | ea0232327-07.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2056263/000121390025044982/0001213900-25-044982-index.htm | https://www.sec.gov/Archives/edgar/data/2056263/000121390025044982/ea0232327-07.htm | initial public offering | 2026-08-02T22:31:41 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002082542 | Bitcoin Infrastructure Acquisition Corp Ltd | BIXI | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001829126-25-009591 | 424B4 | 2025-12-02T00:00:00 | null | 2025-12-02T21:15:29.000Z | null | 333-289903 | 2,349,234 | false | bitcoininfra_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2082542/000182912625009591/0001829126-25-009591-index.htm | https://www.sec.gov/Archives/edgar/data/2082542/000182912625009591/bitcoininfra_424b4.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002086264 | Vine Hill Capital Investment Corp. II | VHCP | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-123758 | 424B4 | 2025-12-19T00:00:00 | null | 2025-12-19T19:46:39.000Z | null | 333-291793 | 3,954,257 | false | ea0257433-09.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2086264/000121390025123758/0001213900-25-123758-index.htm | https://www.sec.gov/Archives/edgar/data/2086264/000121390025123758/ea0257433-09.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002076192 | Westin Acquisition Corp | WSTN | Nasdaq | 6770 | Blank Checks | E9 | 0630 | operating | 0001213900-25-106546 | 424B4 | 2025-11-05T00:00:00 | null | 2025-11-05T13:09:50.000Z | null | 333-288889 | 1,701,826 | false | ea0264189-424b4_westin.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2076192/000121390025106546/0001213900-25-106546-index.htm | https://www.sec.gov/Archives/edgar/data/2076192/000121390025106546/ea0264189-424b4_westin.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002012318 | Inflection Point Acquisition Corp. III | IPCX | Nasdaq | 6770 | Blank Checks | null | 1231 | operating | 0001213900-25-035659 | 424B4 | 2025-04-25T00:00:00 | null | 2025-04-25T17:15:51.000Z | null | 333-283427 | 4,181,806 | false | ea0222072-08.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2012318/000121390025035659/0001213900-25-035659-index.htm | https://www.sec.gov/Archives/edgar/data/2012318/000121390025035659/ea0222072-08.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002070887 | Crown Reserve Acquisition Corp. I | CRAC | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-107267 | 424B4 | 2025-11-06T00:00:00 | null | 2025-11-06T22:31:10.000Z | null | 333-287674 | 4,462,762 | false | ea0242759-14.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2070887/000121390025107267/0001213900-25-107267-index.htm | https://www.sec.gov/Archives/edgar/data/2070887/000121390025107267/ea0242759-14.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002113481 | Osprey Acquisition Corp. III | OSPR | null | 6770 | Blank Checks | E9 | 1231 | other | 0001213900-26-074446 | 424B4 | 2026-07-02T00:00:00 | null | 2026-07-01T22:01:44.000Z | null | 333-296787 | 4,399,541 | false | ea0279881-04.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2113481/000121390026074446/0001213900-26-074446-index.htm | https://www.sec.gov/Archives/edgar/data/2113481/000121390026074446/ea0279881-04.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002033122 | Berto Acquisition Corp. | TACO | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001829126-25-003237 | 424B4 | 2025-05-01T00:00:00 | null | 2025-05-01T01:42:13.000Z | null | 333-286023 | 1,993,072 | false | bertoacquisition_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2033122/000182912625003237/0001829126-25-003237-index.htm | https://www.sec.gov/Archives/edgar/data/2033122/000182912625003237/bertoacquisition_424b4.htm | initial public offering | 2026-08-02T22:31:42 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002087965 | Cantor Equity Partners VII, Inc. | CAES | Nasdaq | 6770 | Blank Checks | E9 | 1231 | other | 0001213900-26-069612 | 424B4 | 2026-06-17T00:00:00 | null | 2026-06-17T20:01:30.000Z | null | 333-296199 | 4,824,094 | false | ea0261707-07.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2087965/000121390026069612/0001213900-26-069612-index.htm | https://www.sec.gov/Archives/edgar/data/2087965/000121390026069612/ea0261707-07.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002025401 | Fifth Era Acquisition Corp I | FERA | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-018222 | 424B4 | 2025-02-28T00:00:00 | null | 2025-02-28T11:33:13.000Z | null | 333-284616 | 3,943,667 | false | ea0207578-14.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2025401/000121390025018222/0001213900-25-018222-index.htm | https://www.sec.gov/Archives/edgar/data/2025401/000121390025018222/ea0207578-14.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002028614 | Drugs Made In America Acquisition Corp. | DMAA | Nasdaq | 6770 | Blank Checks | null | 1231 | operating | 0001213900-25-007724 | 424B4 | 2025-01-29T00:00:00 | null | 2025-01-29T15:16:34.000Z | null | 333-281170 | 4,477,139 | false | ea0209546-15.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2028614/000121390025007724/0001213900-25-007724-index.htm | https://www.sec.gov/Archives/edgar/data/2028614/000121390025007724/ea0209546-15.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002045473 | Copley Acquisition Corp | COPL | NYSE | 6770 | Blank Checks | E9 | 1231 | operating | 0001829126-25-003240 | 424B4 | 2025-05-01T00:00:00 | null | 2025-05-01T14:29:05.000Z | null | 333-283972 | 2,266,552 | false | copleyacq_424b4.htm | 424B4 | https://www.sec.gov/Archives/edgar/data/2045473/000182912625003240/0001829126-25-003240-index.htm | https://www.sec.gov/Archives/edgar/data/2045473/000182912625003240/copleyacq_424b4.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002115404 | Collective Acquisition Corp. II | CAII | null | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-26-049306 | 424B4 | 2026-04-29T00:00:00 | null | 2026-04-29T20:15:25.000Z | null | 333-294701 | 1,930,865 | false | ea0287962-424b4_collective2.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2115404/000121390026049306/0001213900-26-049306-index.htm | https://www.sec.gov/Archives/edgar/data/2115404/000121390026049306/ea0287962-424b4_collective2.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002027708 | Cantor Equity Partners I, Inc. | CEPO | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-001321 | 424B4 | 2025-01-07T00:00:00 | null | 2025-01-07T11:09:19.000Z | null | 333-282947 | 4,255,378 | false | ea0208720-10.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2027708/000121390025001321/0001213900-25-001321-index.htm | https://www.sec.gov/Archives/edgar/data/2027708/000121390025001321/ea0208720-10.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002079933 | TGE Value Creative Solutions Corp | BEBE | NYSE | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-123488 | 424B4 | 2025-12-19T00:00:00 | null | 2025-12-19T11:28:20.000Z | null | 333-289690 | 3,712,261 | false | ea0252220-07.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2079933/000121390025123488/0001213900-25-123488-index.htm | https://www.sec.gov/Archives/edgar/data/2079933/000121390025123488/ea0252220-07.htm | initial public offering | 2026-08-02T22:31:43 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
0002057043 | WEN Acquisition Corp | WENN | Nasdaq | 6770 | Blank Checks | E9 | 1231 | operating | 0001213900-25-044744 | 424B4 | 2025-05-16T00:00:00 | null | 2025-05-16T16:52:34.000Z | null | 333-286872 | 3,854,251 | false | ea0231326-06.htm | PROSPECTUS | https://www.sec.gov/Archives/edgar/data/2057043/000121390025044744/0001213900-25-044744-index.htm | https://www.sec.gov/Archives/edgar/data/2057043/000121390025044744/ea0231326-06.htm | initial public offering | 2026-08-02T22:31:44 | SQj6sq2938L5VocAV | BaPw840nwMGlXn5Fn | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.